Literature DB >> 9855640

Functional coupling of human L-type Ca2+ channels and angiotensin AT1A receptors coexpressed in xenopus laevis oocytes: involvement of the carboxyl-terminal Ca2+ sensors.

M Oz1, M T Melia, N M Soldatov, D R Abernethy, M Morad.   

Abstract

A human recombinant L-type Ca2+ channel (alpha1C,77) was coexpressed with the rat angiotensin AT1A receptor in Xenopus laevis oocytes. In oocytes expressing only alpha1C,77 channels, application of human angiotensin II (1-10 microM) did not affect the amplitude or kinetics of Ba2+ currents (IBa). In sharp contrast, in oocytes coexpressing alpha1C,77 channels and AT1A receptors, application of 1 nM to 1 microM angiotensin gradually and reversibly inhibited IBa, without significantly changing its kinetics. The inhibitory effect of angiotensin on IBa was abolished in oocytes that had been preincubated with losartan (an AT1A receptor antagonist) or thapsigargin or injected with 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetate, pertussis toxin, guanosine-5'-O-(2-thio)diphosphate, or heparin, suggesting that the recombinant alpha1C channels were regulated by angiotensin through G protein-coupled AT1A receptors via activation of the inositol trisphosphate-dependent intracellular Ca2+ release pathway. Consistent with this hypothesis, no cross-signaling occurred between the AT1A receptor and a splice variant of alpha1C lacking Ca2+ sensors (alpha1C,86). The data suggest that the regulation of recombinant L-type Ca2+ channels by angiotensin is mediated by inositol trisphosphate-induced intracellular Ca2+ release and occurs at the molecular motif responsible for the Ca2+-induced inactivation of the channels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855640     DOI: 10.1124/mol.54.6.1106

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  L-type calcium channel gating is modulated by bradykinin with a PKC-dependent mechanism in NG108-15 cells.

Authors:  Mauro Toselli; Vanni Taglietti
Journal:  Eur Biophys J       Date:  2004-11-05       Impact factor: 1.733

2.  Cocaine inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.

Authors:  Murat Oz; Irina Zakharova; Meral Dinc; Toni Shippenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-03       Impact factor: 3.000

3.  Curcumin Acts as a Positive Allosteric Modulator of α7-Nicotinic Acetylcholine Receptors and Reverses Nociception in Mouse Models of Inflammatory Pain.

Authors:  Eslam Gaber El Nebrisi; Deniz Bagdas; Wisam Toma; Halima Al Samri; Anna Brodzik; Yasmin Alkhlaif; Keun-Hang Susan Yang; Frank Christopher Howarth; Imad M Damaj; Murat Oz
Journal:  J Pharmacol Exp Ther       Date:  2018-01-16       Impact factor: 4.030

4.  Volatile anesthetics and endogenous cannabinoid anandamide have additive and independent inhibitory effects on alpha(7)-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes.

Authors:  Shelley N Jackson; Sachin K Singhal; Amina S Woods; Marisela Morales; Toni Shippenberg; Li Zhang; Murat Oz
Journal:  Eur J Pharmacol       Date:  2007-12-28       Impact factor: 4.432

5.  Chick RGS2L demonstrates concentration-dependent selectivity for pertussis toxin-sensitive and -insensitive pathways that inhibit L-type Ca2+ channels.

Authors:  Patrizia Tosetti; Valeria Parente; Vanni Taglietti; Kathleen Dunlap; Mauro Toselli
Journal:  J Physiol       Date:  2003-03-21       Impact factor: 5.182

6.  The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes.

Authors:  Keun-Hang Yang; Sehamuddin Galadari; Dmytro Isaev; Georg Petroianu; Toni S Shippenberg; Murat Oz
Journal:  J Pharmacol Exp Ther       Date:  2010-02-16       Impact factor: 4.030

7.  Menthol binding and inhibition of α7-nicotinic acetylcholine receptors.

Authors:  Abrar Ashoor; Jacob C Nordman; Daniel Veltri; Keun-Hang Susan Yang; Lina Al Kury; Yaroslav Shuba; Mohamed Mahgoub; Frank C Howarth; Bassem Sadek; Amarda Shehu; Nadine Kabbani; Murat Oz
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.